# OnCo record nct06682572 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06682572/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06682572", "NCT06682572" ;
  schema:name "A Study of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in Japanese Patients"@en ;
  schema:alternateName "RAMP201J"@en ;
  schema:description "A phase 2 trial of Avutometinib (VS-6766) + Defactinib (VS-6063) in ovarian cancer, run by Verastem, Inc., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06682572/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06682572> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2024-10-30" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/low-grade-serous-ovarian-cancer/> ;
  onco:companies <https://onco.cc/companies/verastem/> .